Neos Therapeutics
Latest round
- Series C
Last raised
- Jul 2012
Total raised
- $18M
Investors
- 5
About Neos Therapeutics
Neos Therapeutics, Inc.Founded in 2008 and headquartered in Grand Prairie, US, Neos Therapeutics, Inc. is dedicated to providing advanced therapeutic solutions. The company recently underwent a merger with Aytu BioScience, Inc. expected to finalize in 2021. The CEO, Vipin Garg, leads the company in its mission to improve patient outcomes.Neos Therapeutics focuses on developing innovative therapeutics aimed at improving the quality of life for patients with central nervous system conditions. Their premier product, EXXUA™, is designed for the treatment of ADHD, employing unique mechanisms to improve cognitive function and emotional regulation.22 mn. The company aims to introduce additional therapeutic options for ADHD and other CNS disorders, with releases targeted in the coming years. The merger with Aytu BioScience is expected to enhance market reach and operational capabilities, with the goal of accessing new geographical regions and enhancing product distribution to improve patient access.
Who invested in Neos Therapeutics
5 investors across 1 round
See all investors in Neos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jul 16, 2012
Amount
$18M
Investors
Questions about Neos Therapeutics
Who invested in Neos Therapeutics?
Neos Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neos Therapeutics raised?
Neos Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neos Therapeutics last raise money?
Neos Therapeutics's most recent round on record is a Series C, in Jul 2012.
What does Neos Therapeutics do?
Neos Therapeutics is a pharmaceuticals company.
Where is Neos Therapeutics headquartered?
Neos Therapeutics is headquartered in Grand Prairie, US.
Which VCs invest in companies like Neos Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Neos Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Neos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.